Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study-Reference-Cited by-同舟云学术

Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study

Published:2019-04-18 Issue:1 Volume:21 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Kehm Rebecca D., ,Hopper John L.,John Esther M.,Phillips Kelly-Anne,MacInnis Robert J.,Dite Gillian S.,Milne Roger L.,Liao Yuyan,Zeinomar Nur,Knight Julia A.,Southey Melissa C.,Vahdat Linda,Kornhauser Naomi,Cigler Tessa,Chung Wendy K.,Giles Graham G.,McLachlan Sue-Anne,Friedlander Michael L.,Weideman Prue C.,Glendon Gord,Nesci Stephanie,Andrulis Irene L.,Buys Saundra S.,Daly Mary B.,Terry Mary Beth

Funder

National Cancer Institute

Cancer Australia

National Health and Medical Research Council

National Institute of Health

National Institutes of Health, National Cancer Institute, Cancer Epidemiology Training Grant

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-019-1135-y.pdf

Reference57 articles.

1. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358(9291):1389–99.